Topas COC helps mold next-gen wearable insulin delivery devices
from Plastics Today
More than 30 million people in the United States are diagnosed with diabetes, and it is the most costly chronic disease in the country, according to the American Diabetes Association. Fortunately, medtech companies continue to harness technology to develop more-effective, patient-friendly devices to manage diabetes. Cyclic olefin co-polymers (COCs) from Polyplastics Co., Ltd. (Florence, KY) are playing a significant role in the development of these next-generation devices.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063